The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication.
Open accessAbstract
Human immunodeficiency virus type 1 (HIV-1) viral DNA synthesis in quiescent and activated peripheral blood lymphocytes (PBLs) was studied. Incomplete viral DNA (previously demonstrated to be associated with HIV-1 virions) is carried by HIV-1 virions into quiescent and activated PBLs, contributing to the formation of an early viral DNA pool in these cells. The viral DNA is subsequently completed but only extremely slowly and inefficiently in quiescent PBLs compared to that in stimulated PBLs. We find that this correlates with significantly lower levels of dNTP substrates in quiescent compared to activated PBLs. At these low dNTP concentrations, HIV-1 reverse transcriptase acts in a partially distributive manner. Increasing dNTP concentrations from the levels of quiescent PBLs to the levels of activated PBLs increases the processive action of reverse transcriptase, which in turn stimulates rapid and efficient formation of full-length DNA. Furthermore, hydroxyurea treatment of stimulated PBLs decreases the dNTP levels and the DNA synthesis rate to levels comparable to quiescent PBLs. Our data therefore indicate that low levels of dNTP may explain why HIV-1 DNA is synthesized slowly and inefficiently in quiescent PBLs and suggest that pharmacologic induction of low dNTP levels represents a therapeutic approach for inhibition of HIV-1 replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Popovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200935 · Cited by 3,535
Self-citationZack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
HIV-1 replication is controlled at the level of T cell activation and proviral integration.
Stevenson, M., Stanwick, T. L., Dempsey, M. P., & Lamonica, C. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08274.x · Cited by 800
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
McCune, J. M., Rabin, L. B., Feinberg, M. B., Lieberman, M., Kosek, J. C., Reyes, G. R., & Weissman, I. L. (1988) · Cell · doi:10.1016/0092-8674(88)90487-4 · Cited by 610
Quiescent T Lymphocytes as an Inducible Virus Reservoir in HIV-1 Infection
Bukrinsky, M. I., Stanwick, T. L., Dempsey, M. P., & Stevenson, M. (1991) · Science · doi:10.1126/science.1925601 · Cited by 590
Mechanism and fidelity of HIV reverse transcriptase.
Kati, W. M., Johnson, K. A., Jerva, L. F., & Anderson, K. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35706-5 · Cited by 492
Zack, J. A., Haislip, A. M., Krogstad, P., & Chen, I. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1717-1725.1992 · Cited by 400
Human immunodeficiency virus 1 reverse transcriptase
Huber, H. E., McCoy, J. M., Seehra, J. S., & Richardson, C. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83795-4 · Cited by 246
Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses
Trono, D. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4893-4900.1992 · Cited by 228
Sherman, P. A., & Fyfe, J. A. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90420-x · Cited by 211
Cited by
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
Blömer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., & Gage, F. H. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6641-6649.1997 · Cited by 725
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Cara, A., Gallo, R. C., & Lusso, P. (1996) · Nature Medicine · doi:10.1038/nm1196-1244 · Cited by 495
Self-citationBack, N. K., Nijhuis, M., Keulen, W., Boucher, C. A., Oude Essink, B. O., van Kuilenburg, A. B., van Gennip, A. H., & Berkhout, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00777.x · Cited by 406
Resveratrol, a remarkable inhibitor of ribonucleotide reductase
Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., & Guittet, O. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01572-x · Cited by 383
SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+T-cells
Descours, B., Cribier, A., Chable-Bessia, C., Ayinde, D., Rice, G., Crow, Y., Yatim, A., Schwartz, O., Laguette, N., & Benkirane, M. (2012) · Retrovirology · doi:10.1186/1742-4690-9-87 · Cited by 334
Structure and function of the radical enzyme ribonucleotide reductase
Eklund, H., Uhlin, U., Färnegårdh, M., Logan, D. T., & Nordlund, P. (2001) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(01)00014-1 · Cited by 323
Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type 1 Replication
Lori, F., Malykh, A., Cara, A., Sun, D., Weinstein, J. N., Lisziewicz, J., & Gallo, R. C. (1994) · Science · doi:10.1126/science.7973634 · Cited by 317
Self-citationImportance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans
Fairbanks, L. D., Bofill, M., Ruckemann, K., & Simmonds, H. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29682 · Cited by 310
von Schwedler, U., Kornbluth, R. S., & Trono, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.6992 · Cited by 287
Ribonucleotide Reductase Inhibitors and Future Drug Design
Shao, J., Zhou, B., Chu, B., & Yen, Y. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723949 · Cited by 284
Dissecting How CD4 T Cells Are Lost During HIV Infection
Doitsh, G., & Greene, W. C. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.02.012 · Cited by 273
Metadata
- Authors
- Gao, W. Y., Cara, A., Gallo, R. C., & Lori, F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-10
- Volume
- 90
- Issue
- 19
- Pages
- 8925-8928
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2005910303
- Cited by
- 286
- References
- 14
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.